Literature DB >> 24623418

A temporospatial map that defines specific steps at which critical surfaces in the Gag MA and CA domains act during immature HIV-1 capsid assembly in cells.

Bridget A Robinson1, Jonathan C Reed, Clair D Geary, J Victor Swain, Jaisri R Lingappa.   

Abstract

UNLABELLED: During HIV-1 assembly, Gag polypeptides target to the plasma membrane, where they multimerize to form immature capsids that undergo budding and maturation. Previous mutational analyses identified residues within the Gag matrix (MA) and capsid (CA) domains that are required for immature capsid assembly, and structural studies showed that these residues are clustered on four exposed surfaces in Gag. Exactly when and where the three critical surfaces in CA function during assembly are not known. Here, we analyzed how mutations in these four critical surfaces affect the formation and stability of assembly intermediates in cells expressing the HIV-1 provirus. The resulting temporospatial map reveals that critical MA residues act during membrane targeting, residues in the C-terminal CA subdomain (CA-CTD) dimer interface are needed for the stability of the first membrane-bound assembly intermediate, CA-CTD base residues are necessary for progression past the first membrane-bound intermediate, and residues in the N-terminal CA subdomain (CA-NTD) stabilize the last membrane-bound intermediate. Importantly, we found that all four critical surfaces act while Gag is associated with the cellular facilitators of assembly ABCE1 and DDX6. When correlated with existing structural data, our findings suggest the following model: Gag dimerizes via the CA-CTD dimer interface just before or during membrane targeting, individual CA-CTD hexamers form soon after membrane targeting, and the CA-NTD hexameric lattice forms just prior to capsid release. This model adds an important new dimension to current structural models by proposing the potential order in which key contacts within the immature capsid lattice are made during assembly in cells. IMPORTANCE: While much is known about the structure of the completed HIV-1 immature capsid and domains of its component Gag proteins, less is known about the sequence of events leading to formation of the HIV-1 immature capsid. Here we used biochemical and ultrastructural analyses to generate a temporospatial map showing the precise order in which four critical surfaces in Gag act during immature capsid formation in provirus-expressing cells. Because three of these surfaces make important contacts in the hexameric lattices that are found in the completed immature capsid, these data allow us to propose a model for the sequence of events leading to formation of the hexameric lattices. By providing a dynamic view of when and where critical Gag-Gag contacts form during the assembly process and how those contacts function in the nascent capsid, our study provides novel insights into how an immature capsid is built in infected cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24623418      PMCID: PMC4019110          DOI: 10.1128/JVI.03609-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.

Authors:  A Ono; E O Freed
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.

Authors:  A Cimarelli; S Sandin; S Höglund; J Luban
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag.

Authors:  Xiaofeng Guo; Ariel Roldan; Jing Hu; Mark A Wainberg; Chen Liang
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.

Authors:  Anjali Joshi; Kunio Nagashima; Eric O Freed
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay.

Authors:  Akira Ono; Abdul A Waheed; Anjali Joshi; Eric O Freed
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Basic residues in the nucleocapsid domain of Gag are required for interaction of HIV-1 gag with ABCE1 (HP68), a cellular protein important for HIV-1 capsid assembly.

Authors:  Jaisri R Lingappa; Julia E Dooher; Michael A Newman; Patti K Kiser; Kevin C Klein
Journal:  J Biol Chem       Date:  2005-11-07       Impact factor: 5.157

7.  Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.

Authors:  A Ono; D Demirov; E O Freed
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.

Authors:  J C Paillart; H G Göttlinger
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.

Authors:  M T Burniston; A Cimarelli; J Colgan; S P Curtis; J Luban
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

10.  In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.

Authors:  S Campbell; A Rein
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more
  24 in total

Review 1.  How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.

Authors:  Jaisri R Lingappa; Jonathan C Reed; Motoko Tanaka; Kasana Chutiraka; Bridget A Robinson
Journal:  Virus Res       Date:  2014-07-24       Impact factor: 3.303

2.  Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.

Authors:  Takaaki Koma; Osamu Kotani; Kei Miyakawa; Akihide Ryo; Masaru Yokoyama; Naoya Doi; Akio Adachi; Hironori Sato; Masako Nomaguchi
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

3.  Identifying the assembly intermediate in which Gag first associates with unspliced HIV-1 RNA suggests a novel model for HIV-1 RNA packaging.

Authors:  Brook C Barajas; Motoko Tanaka; Bridget A Robinson; Daryl J Phuong; Kasana Chutiraka; Jonathan C Reed; Jaisri R Lingappa
Journal:  PLoS Pathog       Date:  2018-04-17       Impact factor: 6.823

4.  Formation of RNA Granule-Derived Capsid Assembly Intermediates Appears To Be Conserved between Human Immunodeficiency Virus Type 1 and the Nonprimate Lentivirus Feline Immunodeficiency Virus.

Authors:  Jonathan C Reed; Nick Westergreen; Brook C Barajas; Dylan T B Ressler; Daryl J Phuong; John V Swain; Vishwanath R Lingappa; Jaisri R Lingappa
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

5.  Movements of HIV-1 genomic RNA-APOBEC3F complexes and PKR reveal cytoplasmic and nuclear PKR defenses and HIV-1 evasion strategies.

Authors:  Mariana Marin; Sheetal Golem; Susan L Kozak; David Kabat
Journal:  Virus Res       Date:  2015-11-25       Impact factor: 3.303

6.  Subcellular Localization of HIV-1 gag-pol mRNAs Regulates Sites of Virion Assembly.

Authors:  Jordan T Becker; Nathan M Sherer
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

7.  A cationic, C-terminal patch and structural rearrangements in Ebola virus matrix VP40 protein control its interactions with phosphatidylserine.

Authors:  Kathryn Del Vecchio; Cary T Frick; Jeevan B Gc; Shun-Ichiro Oda; Bernard S Gerstman; Erica Ollmann Saphire; Prem P Chapagain; Robert V Stahelin
Journal:  J Biol Chem       Date:  2018-01-18       Impact factor: 5.157

Review 8.  The Host RNAs in Retroviral Particles.

Authors:  Alice Telesnitsky; Sandra L Wolin
Journal:  Viruses       Date:  2016-08-19       Impact factor: 5.048

9.  M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner.

Authors:  Qin Wang; Xiaolin Zhang; Yuling Han; Xinlu Wang; Guangxia Gao
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

Review 10.  Orchestrating the Selection and Packaging of Genomic RNA by Retroviruses: An Ensemble of Viral and Host Factors.

Authors:  Rebecca J Kaddis Maldonado; Leslie J Parent
Journal:  Viruses       Date:  2016-09-20       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.